MYC: Connecting selective transcriptional control to global RNA production

Nature Reviews Cancer

Volumn 15, Issue 10, 2015, Pages 593-607

  Kress, Theresia R ^a   Sabò, Arianna ^a   Amati, Bruno ^a,b  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MYC PROTEIN; RNA; RNA POLYMERASE II; SERUM RESPONSE FACTOR; MESSENGER RNA;

APOPTOSIS; BIOGENESIS; CELL ADHESION; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DNA BINDING; DNA SEQUENCE; ENHANCER REGION; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; HUMAN; NEXT GENERATION SEQUENCING; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN METABOLISM; REVIEW; RIBOSOME; RNA METABOLISM; RNA METHYLATION; RNA PROCESSING; RNA STABILITY; RNA TRANSLATION; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER;

EID: 84942370919     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3984     Document Type: Review

References (197)

1. Vennstrom, B., Sheiness, D., Zabielski, J., & Bishop, J. M. Isolation and characterization of c myc, a cellular homolog of the oncogene (v myc) of avian myelocytomatosis virus strain 29. J. Virol. 42, 773-779 (1982
2. Hayward, W. S., Neel, B. G., & Astrin, S. M. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290, 475-480 (1981
3. Marcu, K. B., Bossone, S. A., & Patel, A. J. myc function and regulation. Annu. Rev. Biochem. 61, 809-860 (1992
4. Wierstra, I., & Alves, J. The c myc promoter: still MysterY and challenge. Adv. Cancer Res. 99, 113-333 (2008
5. Eilers, M., & Eisenman, R. N. Myc's broad reach. Genes Dev. 22, 2755-2766 (2008
6. Tansey, W. P. Mammalian MYC proteins and cancer. New J. Sci. 2014, 757534 (2014
7. Gallant, P. Myc function in Drosophila. Cold Spring Harb. Perspect. Med. 3, a014324 (2013
8. Grifoni, D., & Bellosta, P. Drosophila Myc: a master regulator of cellular performance. Biochim. Biophys. Acta 1849, 570-581 (2015
9. Young, S. L., et al. Premetazoan ancestry of the Myc-Max network. Mol. Biol. Evol. 28, 2961-2971 (2011
10. Land, H., Parada, L. F., & Weinberg, R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602 (1983
11. Gabay, M., Li, Y., & Felsher, D. W. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb. Perspect. Med. 4, a014241 (2014
12. Meyer, N., & Penn, L. Z. Reflecting on 25 years with MYC. Nat. Rev. Cancer 8, 976-990 (2008
13. Ciriello, G., et al. Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45, 1127-1133 (2013
14. Vita, M., & Henriksson, M. The Myc oncoprotein as a therapeutic target for human cancer. Semin. Cancer Biol. 16, 318-330 (2006
15. Arvanitis, C., & Felsher, D. W. Conditional transgenic models define how MYC initiates and maintains tumorigenesis. Semin. Cancer Biol. 16, 313-317 (2006
16. Shachaf, C. M., et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431, 1112-1117 (2004
17. Felsher, D. W., & Bishop, J. M. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4, 199-207 (1999
18. Jain, M., et al. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297, 102-104 (2002
19. Pelengaris, S., Khan, M., & Evan, G. I. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109, 321-334 (2002
20. Soucek, L., et al. Modelling Myc inhibition as a cancer therapy. Nature 455, 679-683 (2008
21. Sodir, N. M., et al. Endogenous Myc maintains the tumor microenvironment. Genes Dev. 25, 907-916 (2011
22. Blackwood, E. M., & Eisenman, R. N. Max: a helix loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251, 1211-1217 (1991
23. Lin, C. Y., et al. Transcriptional amplification in tumor cells with elevated c Myc. Cell 151, 56-67 (2012
24. Nie, Z., et al. c Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151, 68-79 (2012
25. Sabò, A., et al. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature 511, 488-492 (2014
26. Walz, S., et al. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature 511, 483-487 (2014
27. Fernandez, P. C., et al. Genomic targets of the human c Myc protein. Genes Dev. 17, 1115-1129 (2003
28. Zeller, K. I., et al. Global mapping of c Myc binding sites and target gene networks in human B cells. Proc. Natl Acad. Sci. USA 103, 17834-17839 (2006
29. Deaton, A. M., & Bird, A. CpG islands and the regulation of transcription. Genes Dev. 25, 1010-1022 (2011
30. Guccione, E., et al. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat. Cell Biol. 8, 764-770 (2006
31. Kim, J., Chu, J., Shen, X., Wang, J., & Orkin, S. H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132, 1049-1061 (2008
32. Soufi, A., Donahue, G., & Zaret, K. S. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151, 994-1004 (2012
33. Soufi, A., et al. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 161, 555-568 (2015
34. Lin, C. H., Lin, C., Tanaka, H., Fero, M. L., & Eisenman, R. N. Gene regulation and epigenetic remodeling in murine embryonic stem cells by c Myc. PLoS ONE 4, e7839 (2009
35. Lee, B. K., et al. Cell-Type specific and combinatorial usage of diverse transcription factors revealed by genome-wide binding studies in multiple human cells. Genome Res. 22, 9-24 (2012
36. Sabò, A., & Amati, B. Genome recognition by MYC. Cold Spring Harb. Perspect. Med. 4, a014191 (2014
37. Orian, A., et al. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17, 1101-1114 (2003
38. Guo, J., et al. Sequence specificity incompletely defines the genome-wide occupancy of Myc. Genome Biol. 15, 482 (2014
39. Nair, S. K., & Burley, S. K. X ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell 112, 193-205 (2003
40. Sauve, S., Naud, J. F., & Lavigne, P. The mechanism of discrimination between cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors. J. Mol. Biol. 365, 1163-1175 (2007
41. Thomas, L. R., et al. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. Mol. Cell 58, 440-452 (2015
42. Kim, C. H., et al. The chromodomain-containing histone acetyltransferase TIP60 acts as a code reader, recognizing the epigenetic codes for initiating transcription. Biosci. Biotechnol. Biochem. 79, 532-538 (2015
43. Frank, S. R., et al. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 4, 575-580 (2003
44. Perna, D., et al. Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts. Oncogene 31, 1695-1709 (2012
45. Neph, S., et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 489, 83-90 (2012
46. Wang, J., et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res. 22, 1798-1812 (2012
47. Herkert, B., & Eilers, M. Transcriptional repression: the dark side of myc. Genes Cancer 1, 580-586 (2010
48. Schneider, A., Peukert, K., Eilers, M., & Hanel, F. Association of Myc with the zinc-finger protein Miz 1 defines a novel pathway for gene regulation by Myc. Curr. Top. Microbiol. Immunol. 224, 137-146 (1997
49. Seoane, J., et al. TGFβ influences Myc, Miz 1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 3, 400-408 (2001
50. Staller, P., et al. Repression of p15INK4b expression by Myc through association with Miz 1. Nat. Cell Biol. 3, 392-399 (2001
51. Wiese, K. E., et al. Repression of SRF target genes is critical for Myc-dependent apoptosis of epithelial cells. EMBO J. 34, 1554-1571 (2015
52. Yap, C. S., Peterson, A. L., Castellani, G., Sedivy, J. M., & Neretti, N. Kinetic profiling of the c Myc transcriptome and bioinformatic analysis of repressed gene promoters. Cell Cycle 10, 2184-2196 (2011
53. Mao, D. Y., et al. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr. Biol. 13, 882-886 (2003
54. Adhikary, S., & Eilers, M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6, 635-645 (2005
55. Waters, C. M., Littlewood, T. D., Hancock, D. C., Moore, J. P., & Evan, G. I. c myc protein expression in untransformed fibroblasts. Oncogene 6, 797-805 (1991
56. Rudolph, C., Adam, G., & Simm, A. Determination of copy number of c Myc protein per cell by quantitative Western blotting. Anal. Biochem. 269, 66-71 (1999
57. Leone, G., et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell 8, 105-113 (2001
58. Neri, F., et al. Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells. Mol. Cell. Biol. 32, 840-851 (2012
59. Chou, C., et al. c Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells. Nat. Immunol. 15, 884-893 (2014
60. Smith, A. P., et al. A positive role for Myc in TGFβ induced Snail transcription and epithelial-To mesenchymal transition. Oncogene 28, 422-430 (2009
61. Knoepfler, P. S., et al. Myc influences global chromatin structure. EMBO J. 25, 2723-2734 (2006
62. Jackstadt, R., & Hermeking, H. MicroRNAs as regulators and mediators of c MYC function. Biochim. Biophys. Acta 1849, 544-553 (2014
63. Kaur, M., & Cole, M. D. MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase. Cancer Res. 73, 695-705 (2013
64. Cheng, A. S., et al. Combinatorial analysis of transcription factor partners reveals recruitment of c MYC to estrogen receptor-α responsive promoters. Mol. Cell 21, 393-404 (2006
65. Ji, H., et al. Cell-Type independent MYC target genes reveal a primordial signature involved in biomass accumulation. PLoS ONE 6, e26057 (2011
66. Dang, C. V. MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb. Perspect. Med. 3, a014217 (2013
67. Wolf, E., Lin, C. Y., Eilers, M., & Levens, D. L. Taming of the beast: shaping Myc-dependent amplification. Trends Cell Biol. 25, 241-248 (2014
68. Rahl, P. B., et al. c Myc regulates transcriptional pause release. Cell 141, 432-445 (2010
69. Cowling, V. H., & Cole, M. D. The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-Terminal domain independently of direct DNA binding. Mol. Cell. Biol. 27, 2059-2073 (2007
70. Levens, D. Cellular MYCro economics: balancing MYC function with MYC expression. Cold Spring Harb. Perspect. Med. 3, a014233 (2013
71. Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D. Protein and nucleotide biosynthesis are coupled by a single rate limiting enzyme, PRPS2, to drive cancer. Cell 157, 1088-1103 (2014
72. Marguerat, S., & Bahler, J. Coordinating genome expression with cell size. Trends Genet. 28, 560-565 (2012
73. das Neves, R. P., et al. Connecting variability in global transcription rate to mitochondrial variability. PLoS Biol. 8, e1000560 (2010
74. Padovan-Merhar, O., et al. Single mammalian cells compensate for differences in cellular volume and DNA copy number through independent global transcriptional mechanisms. Mol. Cell 58, 339-352 (2015
75. Darzynkiewicz, Z., Traganos, F., & Melamed, M. R. New cell cycle compartments identified by multiparameter flow cytometry. Cytometry 1, 98-108 (1980
76. Chipumuro, E., et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell 159, 1126-1139 (2014
77. Hart, J. R., Roberts, T. C., Weinberg, M. S., Morris, K. V., & Vogt, P. K. MYC regulates the non-coding transcriptome. Oncotarget 5, 12543-12554 (2014
78. Kim, T., et al. MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression. Oncotarget 6, 18780-18789 (2015
79. Loven, J., et al. Revisiting global gene expression analysis. Cell 151, 476-482 (2012
80. Tu, W. B., et al. Myc and its interactors take shape. Biochim. Biophys. Acta 1849, 469-483 (2015
81. Arabi, A., et al. c Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat. Cell Biol. 7, 303-310 (2005
82. Grandori, C., et al. c Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat. Cell Biol. 7, 311-318 (2005
83. Gomez-Roman, N., Grandori, C., Eisenman, R. N., & White, R. J. Direct activation of RNA polymerase III transcription by c Myc. Nature 421, 290-294 (2003
84. Kwak, H., & Lis, J. T. Control of transcriptional elongation. Annu. Rev. Genet. 47, 483-508 (2013
85. Eberhardy, S. R., & Farnham, P. J. Myc recruits P TEFb to mediate the final step in the transcriptional activation of the cad promoter. J. Biol. Chem. 277, 40156-40162 (2002
86. Kanazawa, S., Soucek, L., Evan, G., Okamoto, T., & Peterlin, B. M. c Myc recruits P TEFb for transcription, cellular proliferation and apoptosis. Oncogene 22, 5707-5711 (2003
87. Bouchard, C., Marquardt, J., Bras, A., Medema, R. H., & Eilers, M. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J. 23, 2830-2840 (2004
88. Gargano, B., Amente, S., Majello, B., & Lania, L. P TEFb is a crucial co factor for Myc transactivation. Cell Cycle 6, 2031-2037 (2007
89. Zeitlinger, J., et al. RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat. Genet. 39, 1512-1516 (2007
90. Adelman, K., & Lis, J. T. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat. Rev. Genet. 13, 720-731 (2012
91. Jonkers, I., & Lis, J. T. Getting up to speed with transcription elongation by RNA polymerase II. Nat. Rev. Mol. Cell Biol. 16, 167-177 (2015
92. Koch, H. B., et al. Large-scale identification of c MYC associated proteins using a combined TAP/MudPIT approach. Cell Cycle 6, 205-217 (2007
93. Zhang, Y., et al. Chromatin connectivity maps reveal dynamic promoter-enhancer long-range associations. Nature 504, 306-310 (2013
94. Schoenfelder, S., et al. The pluripotent regulatory circuitry connecting promoters to their long-range interacting elements. Genome Res. 25, 582-597 (2015
95. Dang, C. V. MYC on the path to cancer. Cell 149, 22-35 (2012
96. van Riggelen, J., Yetil, A., & Felsher, D. W. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. Cancer 10, 301-309 (2010
97. Lodish, H., et al. Molecular Cell Biology 4th edn (W. H. Freeman, 2000
98. Grewal, S. S., Li, L., Orian, A., Eisenman, R. N., & Edgar, B. A. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat. Cell Biol. 7, 295-302 (2005
99. Poortinga, G., et al. MAD1 and c MYC regulate UBF and rDNA transcription during granulocyte differentiation. EMBO J. 23, 3325-3335 (2004
100. Jones, R. M., et al. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c myc. Mol. Cell. Biol. 16, 4754-4764 (1996
101. Rosenwald, I. B., Rhoads, D. B., Callanan, L. D., Isselbacher, K. J., & Schmidt, E. V. Increased expression of eukaryotic translation initiation factors eIF 4E and eIF 2α in response to growth induction by c myc. Proc. Natl Acad. Sci. USA 90, 6175-6178 (1993
102. Iritani, B. M., & Eisenman, R. N. c Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl Acad. Sci. USA 96, 13180-13185 (1999
103. Schuhmacher, M., et al. Control of cell growth by c Myc in the absence of cell division. Curr. Biol. 9, 1255-1258 (1999
104. Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N., & Gallant, P. Drosophila myc regulates cellular growth during development. Cell 98, 779-790 (1999
105. Barna, M., et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456, 971-975 (2008
106. Gandin, V., et al. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation. Nature 455, 684-688 (2008
107. Fernandez-Sanchez, M. E., Gonatopoulos-Pournatzis, T., Preston, G., Lawlor, M. A., & Cowling, V. H. S adenosyl homocysteine hydrolase is required for Myc-induced mRNA cap methylation, protein synthesis, and cell proliferation. Mol. Cell. Biol. 29, 6182-6191 (2009
108. Cole, M. D., & Cowling, V. H. Specific regulation of mRNA cap methylation by the c Myc and E2F1 transcription factors. Oncogene 28, 1169-1175 (2009
109. Koromilas, A. E., Lazaris-Karatzas, A., & Sonenberg, N. mRNAs containing extensive secondary structure in their 5? non-coding region translate efficiently in cells overexpressing initiation factor eIF 4E. EMBO J. 11, 4153-4158 (1992
110. Liu, Y. C., et al. Global regulation of nucleotide biosynthetic genes by c Myc. PLoS ONE 3, e2722 (2008
111. Wang, R., et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35, 871-882 (2011
112. Miltenberger, R. J., Sukow, K. A., & Farnham, P. J. An E box-mediated increase in cad transcription at the G1/S phase boundary is suppressed by inhibitory c Myc mutants. Mol. Cell. Biol. 15, 2527-2535 (1995
113. Nikiforov, M. A., et al. A functional screen for Myc responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol. Cell. Biol. 22, 5793-5800 (2002
114. Li, F., et al. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol. 25, 6225-6234 (2005
115. Cai, L., Sutter, B. M., Li, B., & Tu, B. P. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol. Cell 42, 426-437 (2011
116. Morrish, F., et al. Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry. J. Biol. Chem. 285, 36267-36274 (2010
117. Lu, C., & Thompson, C. B. Metabolic regulation of epigenetics. Cell. Metab. 16, 9-17 (2012
118. Huang, C. H., et al. CDK9 mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. Genes Dev. 28, 1800-1814 (2014
119. Tilgner, H., et al. Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co transcriptional in the human genome but inefficient for lncRNAs. Genome Res. 22, 1616-1625 (2012
120. Fu, X. D., & Ares, M. Jr. Context-dependent control of alternative splicing by RNA-binding proteins. Nat. Rev. Genet. 15, 689-701 (2014
121. Davis-Turak, J. C., et al. Considering the kinetics of mRNA synthesis in the analysis of the genome and epigenome reveals determinants of co transcriptional splicing. Nucleic Acids Res. 43, 699-707 (2015
122. Hubert, CG., et al. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A. Genes Dev. 27, 1032-1045 (2013
123. Koh, C. M., et al. MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis. Nature 523, 96-100 (2015
124. Hsu, T Y. T., et al. The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature http://dx. doi.org/10.1038/nature14985 (2015
125. Anczukow, O., et al. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat. Struct. Mol. Biol. 19, 220-228 (2012
126. Das, S., Anczukow, O., Akerman, M., & Krainer, A. R. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. Cell Rep. 1, 110-117 (2012
127. David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. HnRNP proteins controlled by c Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463, 364-368 (2010
128. Hirsch, C. L., et al. Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming. Genes Dev. 29, 803-816 (2015
129. Fujii, M., et al. SNIP1 is a candidate modifier of the transcriptional activity of c Myc on E box-dependent target genes. Mol. Cell 24, 771-783 (2006
130. Bracken, C P., et al. Regulation of cyclin D1 RNA stability by SNIP1. Cancer Res. 68, 7621-7628 (2008
131. Rounbehler, R. J., et al. Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state. Cell 150, 563-574 (2012
132. Gruber, A. R., Fallmann, J., Kratochvill, F., Kovarik, P., & Hofacker, I. L. AREsite: a database for the comprehensive investigation of AU rich elements. Nucleic Acids Res. 39, D66-D69 (2011
133. Mukherjee, N., et al Global target mRNA specification and regulation by the RNA-binding protein ZFP36. Genome Biol. 15, R12 (2014
134. Houseley, J., & Tollervey, D. The many pathways of RNA degradation. Cell 136, 763-776 (2009
135. Schweingruber, C., Rufener, S. C., Zund, D., Yamashita, A., & Muhlemann, O. Nonsense-mediated mRNA decay-mechanisms of substrate mRNA recognition and degradation in mammalian cells. Biochim. Biophys. Acta 1829, 612-623 (2013
136. Wang, D., Wengrod, J., & Gardner, L. B. Overexpression of the c myc oncogene inhibits nonsense-mediated RNA decay in B lymphocytes. J. Biol. Chem. 286, 40038-40043 (2011
137. Januszyk, K., & Lima, C. D. The eukaryotic RNA exosome. Curr. Opin. Struct. Biol. 24, 132-140 (2014
138. Carroll, P. A., et al. Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis. Cancer Cell 27, 271-285 (2015
139. Gartel, A. L., et al. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc. Natl Acad. Sci. USA 98, 4510-4515 (2001
140. Izumi, H., et al. Mechanism for the transcriptional repression by c Myc on PDGF β-receptor. J. Cell Sci. 114, 1533-1544 (2001
141. Feng, X. H., Liang, Y. Y., Liang, M., Zhai, W., & Lin, X. Direct interaction of c Myc with Smad2 and Smad3 to inhibit TGF-β-mediated induction of the CDK inhibitor p15Ink4B. Mol. Cell 9, 133-143 (2002
142. Shrivastava, A., et al. Inhibition of transcriptional regulator Yin-Yang 1 by association with c Myc. Science 262, 1889-1892 (1993
143. Brenner, C., et al. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 24, 336-346 (2005
144. Wolf, E., et al. Miz1 is required to maintain autophagic flux. Nat. Commun. 4, 2535 (2013
145. Barrilleaux, B. L., et al. Miz 1 activates gene expression via a novel consensus DNA binding motif. PLoS ONE 9, e101151 (2014
146. Yang, W., et al. Repression of transcription of the p27Kip1 cyclin-dependent kinase inhibitor gene by c Myc. Oncogene 20, 1688-1702 (2001
147. Herold, S., et al. Negative regulation of the mammalian UV response by Myc through association with Miz 1. Mol. Cell 10, 509-521 (2002
148. Warner, B. J., Blain, S. W., Seoane, J., & Massague, J. Myc downregulation by transforming growth factor β required for activation of the p15Ink4b G1 arrest pathway. Mol. Cell. Biol. 19, 5913-5922 (1999
149. van Riggelen, J., et al. The interaction between Myc and Miz1 is required to antagonize TGFβ-dependent autocrine signaling during lymphoma formation and maintenance. Genes Dev. 24, 1281-1294 (2010
150. Gebhardt, A., et al. Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1. J. Cell Biol. 172, 139-149 (2006
151. Wilson, A., et al. c Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18, 2747-2763 (2004
152. Langdon, W. Y., Harris, A. W., Cory, S., & Adams, J. M. The c myc oncogene perturbs B lymphocyte development in E mu myc transgenic mice. Cell 47, 11-18 (1986
153. Vaux, D. L., Adams, J. M., Alexander, W. S., & Pike, B. L. Immunologic competence of B cells subjected to constitutive c myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic mice. J. Immunol. 139, 3854-3860 (1987
154. Leon, J., Ferrandiz, N., Acosta, J. C., & Delgado, M. D. Inhibition of cell differentiation: a critical mechanism for MYC-mediated carcinogenesis? Cell Cycle 8, 1148-1157 (2009
155. Lawlor, E. R., et al. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc mediated tumorigenesis. Cancer Res. 66, 4591-4601 (2006
156. Palomero, T., et al. NOTCH1 directly regulates c MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc. Natl Acad. Sci. USA 103, 18261-18266 (2006
157. Sharma, V. M., et al. Notch1 contributes to mouse T cell leukemia by directly inducing the expression of c myc. Mol. Cell. Biol. 26, 8022-8031 (2006
158. Weng, A. P., et al. c Myc is an important direct target of Notch1 in T cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 20, 2096-2109 (2006
159. Sansom, O. J., et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 446, 676-679 (2007
160. He, T. C., et al. Identification of c MYC as a target of the APC pathway. Science 281, 1509-1512 (1998
161. Berman, D. M., et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297, 1559-1561 (2002
162. Sicklick, J. K., et al. Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 27, 748-757 (2006
163. Bromberg, J. F., et al. Stat3 as an oncogene. Cell 98, 295-303 (1999
164. Kiuchi, N., et al. STAT3 is required for the gp130 mediated full activation of the c myc gene. J. Exp. Med. 189, 63-73 (1999
165. Chen, C. R., Kang, Y., Siegel, P. M., & Massague, J. E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c myc repression. Cell 110, 19-32 (2002
166. Frederick, J. P., Liberati, N. T., Waddell, D. S., Shi, Y., & Wang, X. F. Transforming growth factor β-mediated transcriptional repression of c myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell. Biol. 24, 2546-2559 (2004
167. Csibi, A., et al. The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B dependent control of c Myc translation. Curr. Biol. 24, 2274-2280 (2014
168. Wall, M., et al. Translational control of c MYC by rapamycin promotes terminal myeloid differentiation. Blood 112, 2305-2317 (2008
169. Notari, M., et al. A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood 107, 2507-2516 (2006
170. Kress, T. R., et al. The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis. Mol. Cell 41, 445-457 (2011
171. Sears, R., Leone, G., DeGregori, J., & Nevins, J. R. Ras enhances Myc protein stability. Mol. Cell 3, 169-179 (1999
172. Sears, R., et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14, 2501-2514 (2000
173. Dai, M S., Sears, R., & Lu, H. Feedback regulation of c Myc by ribosomal protein L11. Cell Cycle 6, 2735-2741 (2007
174. Kim, S., Li, Q., Dang, C. V., & Lee, L. A. Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c Myc in vivo. Proc. Natl Acad. Sci. USA 97, 11198-11202 (2000
175. Perez-Roger, I., Kim, S H., Griffiths, B., Sewing, A., & Land, H. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27Kip1 and p21Cip1. EMBO J. 18, 5310-5320 (1999
176. Yu, Q., Ciemerych, M. A., & Sicinski, P. Ras and Myc can drive oncogenic cell proliferation through individual D cyclins. Oncogene 24, 7114-7119 (2005
177. Beier, R., et al. Induction of cyclin E-cdk2 kinase activity, E2F dependent transcription and cell growth by Myc are genetically separable events. EMBO J. 19, 5813-5823 (2000
178. Perez-Roger, I., Solomon, D. L., Sewing, A., & Land, H. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes. Oncogene 14, 2373-2381 (1997
179. Mitchell, K. O., et al. Bax is a transcriptional target and mediator of c myc-induced apoptosis. Cancer Res. 60, 6318-6325 (2000
180. Nikiforov, M. A., et al. Tumor cell-selective regulation of NOXA by c MYC in response to proteasome inhibition. Proc. Natl Acad. Sci. USA 104, 19488-19493 (2007
181. Egle, A., Harris, A. W., Bouillet, P., & Cory, S. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl Acad. Sci. USA 101, 6164-6169 (2004
182. Hemann, M. T., et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436, 807-811 (2005
183. Eischen, C. M., Woo, D., Roussel, M. F., & Cleveland, J. L. Apoptosis triggered by Myc-induced suppression of Bcl XL or Bcl 2 is bypassed during lymphomagenesis. Mol. Cell. Biol. 21, 5063-5070 (2001
184. Maclean, K. H., Keller, U. B., Rodriguez-Galindo, C., Nilsson, J. A., & Cleveland, J. L. c Myc augments gamma irradiation-induced apoptosis by suppressing Bcl XL. Mol. Cell. Biol. 23, 7256-7270 (2003
185. Kim, J. W., Gao, P., Liu, Y. C., Semenza, G. L., & Dang, C. V. Hypoxia-inducible factor 1 and dysregulated c Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell. Biol. 27, 7381-7393 (2007
186. Shim, H., et al. c Myc transactivation of LDH A: implications for tumor metabolism and growth. Proc. Natl Acad. Sci. USA 94, 6658-6663 (1997
187. Wise, D. R., et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl Acad. Sci. USA 105, 18782-18787 (2008
188. Gao, P., et al. c Myc suppression of miR 23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762-765 (2009
189. Zhang, H., et al. HIF 1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C MYC activity. Cancer Cell 11, 407-420 (2007
190. Fogal, V., et al. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction. Oncotarget 6, 1157-1170 (2015
191. Zeller, K. I., Jegga, A. G., Aronow, B. J., O'Donnell, K. A., & Dang, C. V. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol. 4, R69 (2003
192. Valovka, T., et al. Transcriptional control of DNA replication licensing by Myc. Sci. Rep. 3, 3444 (2013
193. Dominguez-Sola, D., et al. Non-Transcriptional control of DNA replication by c Myc. Nature 448, 445-451 (2007
194. Kwan, K. Y., Shen, J., & Corey, D. P. C MYC transcriptionally amplifies SOX2 target genes to regulate self-renewal in multipotent otic progenitor cells. Stem Cell Rep. 4, 47-60 (2015
195. Tao, J., & Zhao, X. c MYC-miRNA circuitry: a central regulator of aggressive B cell malignancies. Cell Cycle 13, 191-198 (2014
196. Chang, T. C., et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nature Genet. 40, 43-50 (2008
197. Seitz, V., et al. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS ONE 6, e26837 (2011